BIAF vs. ONMD, NOTV, DKDCA, AIKI, FOXO, ISPC, IQV, ICLR, INCY, and MEDP
Should you be buying bioAffinity Technologies stock or one of its competitors? The main competitors of bioAffinity Technologies include OneMedNet (ONMD), Inotiv (NOTV), Data Knights Acquisition (DKDCA), AIkido Pharma (AIKI), FOXO Technologies (FOXO), iSpecimen (ISPC), IQVIA (IQV), ICON Public (ICLR), Incyte (INCY), and Medpace (MEDP). These companies are all part of the "commercial physical research" industry.
bioAffinity Technologies (NASDAQ:BIAF) and OneMedNet (NASDAQ:ONMD) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their profitability, risk, media sentiment, community ranking, dividends, institutional ownership, analyst recommendations, earnings and valuation.
1.6% of bioAffinity Technologies shares are owned by institutional investors. Comparatively, 1.0% of OneMedNet shares are owned by institutional investors. 36.4% of bioAffinity Technologies shares are owned by company insiders. Comparatively, 45.7% of OneMedNet shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.
In the previous week, OneMedNet had 2 more articles in the media than bioAffinity Technologies. MarketBeat recorded 4 mentions for OneMedNet and 2 mentions for bioAffinity Technologies. OneMedNet's average media sentiment score of 1.29 beat bioAffinity Technologies' score of 0.29 indicating that OneMedNet is being referred to more favorably in the news media.
bioAffinity Technologies has higher revenue and earnings than OneMedNet. OneMedNet is trading at a lower price-to-earnings ratio than bioAffinity Technologies, indicating that it is currently the more affordable of the two stocks.
bioAffinity Technologies has a beta of 3.15, suggesting that its stock price is 215% more volatile than the S&P 500. Comparatively, OneMedNet has a beta of -0.46, suggesting that its stock price is 146% less volatile than the S&P 500.
OneMedNet has a net margin of 0.00% compared to bioAffinity Technologies' net margin of -171.43%. OneMedNet's return on equity of 0.00% beat bioAffinity Technologies' return on equity.
bioAffinity Technologies and OneMedNet both received 0 outperform votes by MarketBeat users.
Summary
OneMedNet beats bioAffinity Technologies on 7 of the 13 factors compared between the two stocks.
Get bioAffinity Technologies News Delivered to You Automatically
Sign up to receive the latest news and ratings for BIAF and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding BIAF and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
bioAffinity Technologies Competitors List
Related Companies and Tools
